Eli Lilly Zepbound Results

Order byBest matchMost fresh

Wegovy, Zepbound and Eli Lilly

Top News

Overview

Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy

The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.

· 1d · on MSN

Stocktwits on MSN · 1d

Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders Wary

· 1d · on MSN

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

First head-to-head trial found Zepbound beats Wegovy for weight loss

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

· 22h

· 1d

New study compares Wegovy and Zepbound for the first time

· 1d

Study finds Zepbound may help people lose more weight than Wegovy

17h

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the rival medicines.

11don MSN

Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell roughly 10% on investor worries that the move could blunt its sales momentum.